鲍曼不动杆菌
细菌
微生物学
两亲性
细胞穿透肽
寡核苷酸
肽
肽核酸
生物
基因
化学
生物化学
遗传学
共聚物
铜绿假单胞菌
聚合物
有机化学
作者
Chen Zhou,Dan Nie,Yue Hu,Mingkai Li,Zheng Hou,Xinggang Mao,Xiaoxing Luo,Xiaoyan Xue
标识
DOI:10.2174/1567201816666190627141931
摘要
BACKGROUND: Carbapenem-resistant Acinetobacter baumannii (A. baumannii) was on the top of the list of the most threatening bacteria published by the WHO in 2017. Antisense oligonucleotides (ASOs) based therapy is a promising strategy for combating Multi-Drug Resistant (MDR) bacteria because of its high specificity, easy design and lower induction of resistance, but poor cellular uptake by bacteria has restricted the further utilization of this therapy. METHODS: Here, we used CADY, a secondary amphipathic peptide of 20 residues that could successfully carry siRNA into mammalian cells, to prepare CADY/ASOs nanoparticles (CADY-NPs) targeting acpP (encoding acyl carrier protein), and evaluated the uptake features, the inhibitory effects of CADY-NPs on gene expression and the growth of MDR-A. baumannii. RESULTS: We found that CADY-NPs could be quickly internalized by drug-sensitive and MDR-A. baumannii in an energy independent manner, which could be restrained by chlorpromazine (an inhibitor of clathrin mediated endocytosis) significantly. In addition, CADY-NPs targeting acpP concentrationdependently retarded the growth of MDR-A. baumannii, which was associated with the decreased expression of targeted genes in A. baumannii. CONCLUSION: In conclusion, our research is the first to demonstrate that CADY can deliver ASOs into bacteria and provide a novel strategy for the treatment of MDR-A. baumannii.
科研通智能强力驱动
Strongly Powered by AbleSci AI